ArticleJournal of clinical and translational hepatology2026

Targeting the 4EBP1/HSP90β/Nrf2 Axis Sensitizes β-catenin-mutant Hepatocellular Carcinoma to mTOR Inhibitors via Ferroptosis Induction.

Rong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.